Stephen Cho

Most Recent Articles by Stephen Cho

Single-agent Ibrutinib Therapy Provides Durable Response in CLL/SLL

Single-agent Ibrutinib Therapy Provides Durable Response in CLL/SLL

By

Treatment with single-agent ibrutinib was well-tolerated and provided durable responses in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).

Pembrolizumab Demonstrates Anti-tumor Activity, Acceptable Safety Profile in Urothelial Cancer

Pembrolizumab Demonstrates Anti-tumor Activity, Acceptable Safety Profile in Urothelial Cancer

By

For the treatment of patients with advanced urothelial cancer, pembrolizumab demonstrated anti-tumor activity and an acceptable safety profile.

Diagnostic Laparoscopy: A Way To Reduce Likelihood of Futile Laparotomy?

Diagnostic Laparoscopy: A Way To Reduce Likelihood of Futile Laparotomy?

By

Treatment with diagnostic laparoscopy rather than primary surgery may lower the rate of futile laparotomies among women with suspected advanced ovarian cancer.

Asian Men With Metastatic PCa Have Superior ADT Outcomes

Asian Men With Metastatic PCa Have Superior ADT Outcomes

By

Those of Asian ethnicity have superior median overall and PCa-specific survival to men of any other race.

Diarrhea Manageable With Pertuzumab Treatment for Breast Cancer

Diarrhea Manageable With Pertuzumab Treatment for Breast Cancer

By

Diarrhea is a common but manageable side effect for patients with HER2-positive breast cancer undergoing treatment with pertuzumab.

More Articles by Stephen Cho

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters